Breaking
PLPolicja potwierdza obecność Romanowskiego w Naddniestrzu, Interpol wciąż milczyKR러시아 유조선, 우크라이나 드론 공격 피하기 위해 그물망 설치INTLIsraeli Settlers Besiege Palestinian Families in Occupied West BankDETrump-Plattform Truth Social: Kritik und Klage gegen PremiumangebotFRLes sapeurs-pompiers français appelés à la grève pour demander davantage de moyensEULibyan National Army's Intelligence Head Killed in Benghazi Car BombingCRYPTO-ENBank of England Tests Digital Pound and Stablecoin Integration in Cross-Border Trade Finance ExperimentCN2026城鎮韌性(防空)演習北部地區登場BRANP Atualiza Regras para Comercialização de Biometano no BrasilCNUS-China Trade Talks: Private Sector Discussions Not Yet InitiatedPLPolicja potwierdza obecność Romanowskiego w Naddniestrzu, Interpol wciąż milczyKR러시아 유조선, 우크라이나 드론 공격 피하기 위해 그물망 설치INTLIsraeli Settlers Besiege Palestinian Families in Occupied West BankDETrump-Plattform Truth Social: Kritik und Klage gegen PremiumangebotFRLes sapeurs-pompiers français appelés à la grève pour demander davantage de moyensEULibyan National Army's Intelligence Head Killed in Benghazi Car BombingCRYPTO-ENBank of England Tests Digital Pound and Stablecoin Integration in Cross-Border Trade Finance ExperimentCN2026城鎮韌性(防空)演習北部地區登場BRANP Atualiza Regras para Comercialização de Biometano no BrasilCNUS-China Trade Talks: Private Sector Discussions Not Yet Initiated
Newsgather
BackPoland Appeals EU Court Ruling on Undelivered Pfizer COVID-19 Vaccines
Poland Appeals EU Court Ruling on Undelivered Pfizer COVID-19 Vaccines
Health
Politico EU8/4/2026Health2 min read

Poland Appeals EU Court Ruling on Undelivered Pfizer COVID-19 Vaccines

Seeks to Freeze Provisional Enforcement of €1.3 Billion Payment Order

Quick Look

Poland appeals a Brussels court ruling to pay Pfizer €1.3 billion for 64 million unwanted COVID-19 vaccine doses, citing overlooked factual and legal circumstances, and seeks to freeze the order's enforcement.

AI-generated summary

Why It Matters

The dispute stems from a 2021 EU-Pfizer contract for COVID-19 vaccines, which Poland stopped accepting in 2022 due to low demand and the Ukraine war's impact.

Font size

Poland on Monday appealed a Brussels court judgment ordering it to take delivery of roughly 64 million unwanted Covid-19 doses and pay Pfizer about €1.3 billion. Warsaw also asked judges to freeze the ruling’s provisional enforcement while the challenge is heard.

“The decision of the court of first instance does not take into account all the relevant factual and legal circumstances of the case,” the Health Ministry said in a statement. It added that Poland would use “all legal means of defense,” but declined to disclose its arguments or evidence, citing the need to protect the state’s interests.

The ruling which Poland appealed relates to a 2021 agreement the European Commission negotiated with Pfizer on behalf of EU countries. Poland stopped accepting vaccine deliveries in 2022, citing collapsing demand and the impact of Russia's war against Ukraine. Pfizer sued Poland and Romania the following year.

In April 2026, a Brussels court ruled that Warsaw remained bound by the contract and ordered it to pay roughly €1.3 billion, plus interest and legal costs, for the undelivered doses. Pfizer defended the Belgian judgment, which it told POLITICO reflected “the importance of the contractual obligations that underpinned a successful European pandemic response, built on the principle of solidarity between Member States.”

The company said it was taking “appropriate steps” to ensure compliance through “established legal enforcement mechanisms,” adding that those efforts followed “years of discussions and significant flexibility to accommodate Member States' circumstances.”

What to Watch

AI outlook — possibilities, not facts

  • Poland's appeal may lead to a reevaluation of EU vaccine contract terms.

    Likely · Within weeks

Open Questions

  • What are Poland's specific legal arguments?
  • How will the EU respond to the appeal?

Related Topics

This article was originally published by Politico EU.

Related Stories

More on this topicCOVID-19 Vaccines